Mutations in PLOD2 cause autosomal-recessive connective tissue disorders within the Bruck syndrome-Osteogenesis imperfecta phenotypic spectrum

Maria Trinidad Puig-Hervás(Consejo Superior de Investigaciones Científicas), Samia A. Temtamy(National Water Research Center), Mona Aglan(National Water Research Center), Maria Valencia(Consejo Superior de Investigaciones Científicas), Víctor Martínez‐Glez(Hospital Universitario La Paz), María Juliana Ballesta‐Martínez(Hospital Universitario Virgen de la Arrixaca), Vanesa López‐González(Hospital Universitario Virgen de la Arrixaca), Adel M. Ashour(National Water Research Center), Khalda Amr(National Water Research Center), Verónica Pulido(Consejo Superior de Investigaciones Científicas), Encarna Guillén‐Navarro(Hospital Universitario Virgen de la Arrixaca), Pablo Lapunzina(Hospital Universitario La Paz), José A. Caparrós‐Martín(Consejo Superior de Investigaciones Científicas), Víctor L. Ruiz‐Pérez(Consejo Superior de Investigaciones Científicas)
Human Mutation
June 11, 2012
Cited by 97

Abstract

PLOD2 and FKBP10 are genes mutated in Bruck syndrome (BS), a condition resembling osteogenesis imperfecta (OI), but that is also typically associated with congenital joint contractures. Herein, we sought mutations in six consanguineous BS families and detected changes in either PLOD2 or FKBP10 in all cases. Two probands were found with a homozygous frameshift mutation in the alternative exon 13a of PLOD2, indicating that specific inactivation of the longer protein isoform encoded by this gene is sufficient to cause BS. In addition, by homozygosity mapping, followed by a candidate gene approach, we identified a homozygous donor splice site mutation in PLOD2 in a patient with autosomal-recessive OI (AR-OI). Screening of additional samples also revealed compound heterozygous mutations in PLOD2 in two brothers, one affected with mild AR-OI and the other with mild BS. Thus, PLOD2 in addition to causing BS is also associated with AR-OI phenotypes of variable severity.


Related Papers